|
| | Publication Year | Title | Author(s) |
| 41 | 27-Oct-2008 | Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastases. | Daruwalla, Jurstine; Greish, Khaled; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Iyer, Arun; Maeda, Hiroshi; Christophi, Christopher |
| 42 | 18-Aug-2013 | Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor. | Fifis, Theodora; Nguyen, Linh; Malcontenti-Wilson, Caterina; Chan, Lie Sam; Nunes Costa, Patricia Luiza; Daruwalla, Jurstine; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Waltham, Mark; Thompson, Erik W; Christophi, Christopher |
| 3 | 31-Jul-2013 | Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met. | Harun, Nadia; Costa, Patricia; Christophi, Christopher |
| 4 | 21-Nov-2007 | Vaccination with in vitro grown whole tumor cells induces strong immune responses and retards tumor growth in a murine model of colorectal liver metastases. | Fifis, Theodora; Lam, Irene; Lin, Doris; Malcontenti-Wilson, Caterina; Christophi, Christopher ; Loveland, Bruce |
| 5 | 7-Jun-2007 | Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model. | Malcontenti-Wilson, Caterina; Chan, Lisa; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Christophi, Christopher |
